CompletedNCT01355952
Alpha-Lipoic Acid Studied for Weight Management in Schizophrenia
About this title
Read the official source — NCT01355952Interventional studyAges 18–70United States
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.
- Listed locations
- New HavenSee all locations and recruitment
Study information
Study start dateMay 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 17
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Other
- Intervention type
- DIETARY_SUPPLEMENT
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT01355952
- Official title
Show the full official title
An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New Haven
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.
